Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3856 AL 3870

Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging?

Sellami M, Gasmi M, Denham J, Hayes LD, Stratton D, Padulo J, Bragazzi N.

Front Immunol. 2018 Oct 10;9:2187. doi: 10.3389/fimmu.2018.02187. eCollection 2018.

Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer's Disease

Wolinsky D, Drake K, Bostwick J.

Curr Psychiatry Rep. 2018 Oct 27;20(12):117. doi: 10.1007/s11920-018-0978-8.

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease

Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.

Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study

Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Am Heart Assoc. 2018 Sep 18;7(18):e009742. doi: 10.1161/JAHA.118.009742.

Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology

Uddin MS, Al Mamun A, Kabir MT, Jakaria M, Mathew B, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Jul;56(7):4925-4944. doi: 10.1007/s12035-018-1420-2. Epub 2018 Nov 9.

The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease

Lu MH, Zhao XY, Yao PP, Xu DE, Ma QH.

Neurosci Bull. 2018 Dec;34(6):1127-1130. doi: 10.1007/s12264-018-0310-y. Epub 2018 Nov 12.

Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review

Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y.

Clin Interv Aging. 2018 Oct 18;13:2061-2073. doi: 10.2147/CIA.S184968. eCollection 2018.

Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease

Silva CFM, Pinto DCGA, Silva AMS.

Expert Opin Drug Discov. 2018 Dec;13(12):1141-1151. doi: 10.1080/17460441.2018.1543267. Epub 2018 Nov 15.

Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Med Chem. 2019 May 9;62(9):4252-4264. doi: 10.1021/acs.jmedchem.8b01530. Epub 2018 Nov 30.

Geroneuroprotectors: Effective Geroprotectors for the Brain

Schubert D, Currais A, Goldberg J, Finley K, Petrascheck M, Maher P.

Trends Pharmacol Sci. 2018 Dec;39(12):1004-1007. doi: 10.1016/j.tips.2018.09.008. Epub 2018 Nov 13.

Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly

Lee BI, Chung YJ, Park CB.

Biomaterials. 2019 Jan;190-191:121-132. doi: 10.1016/j.biomaterials.2018.10.043. Epub 2018 Oct 30.

Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis

Okuya M, Matsunaga S, Ikuta T, Kishi T, Iwata N.

J Alzheimers Dis. 2018;66(4):1379-1387. doi: 10.3233/JAD-180888.

Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease

Pradeepkiran JA, Reddy AP, Reddy PH.

Drug Discov Today. 2019 Feb;24(2):616-623. doi: 10.1016/j.drudis.2018.11.005. Epub 2018 Nov 16.

Comparison of Cognitive Intervention Strategies for Older Adults With Mild to Moderate Alzheimer's Disease: A Bayesian Meta-analytic Review

Liang JH, Li JY, Jia RX, Wang YQ, Wu RK, Zhang HB, Hang L, Xu Y, Pan CW.

J Am Med Dir Assoc. 2019 Mar;20(3):347-355. doi: 10.1016/j.jamda.2018.09.017. Epub 2018 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias